⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Hidradenitis Suppurativa Market Opportunity Forecast Report 2025: 7MM Market to Reach $7.8 Billion by 2034, Driven by New Biologics and Small-Molecule Launches Including Sonelokimab and Povorcitinib
globenewswire.com
ABBV
INCY
JNJ
MRK
NVS
SNY
Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight
globenewswire.com
WEX
ATX
ASMF
VELO
WSNT
LEX
VRTX
PFE
REGN
LLY
GSK
NVO
ISPC
MRK
SCIX
DNA Damaging Agents Market Grows at 11.67% CAGR, to Hit USD 46.31 Billion by 2034
globenewswire.com
XRAY
NVS
RUC
NIRA
TLZ
AZN
BMY
MRK
Merck to Participate in the Citi 2025 Global Healthcare Conference
businesswire.com
MRK
IMFINZI® approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers
businesswire.com
AZN
DAI
MRK
Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference
businesswire.com
MRK
Merck Sharp & Dohme LLC Data Breach - Levi & Korsinsky, LLP Launches Investigation
accessnewswire.com
MRK
Liver Cancer Drug Market Poised to Reach US$ 17.2 Billion by 2033 Amid Rapid Advances in Targeted Therapies | Astute Analytica
globenewswire.com
BMY
MRK
AZN
ELVN
REGN
GILD
NVS
SNY
Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight
globenewswire.com
GSK
TREVI
MRK
AZN
SNY
TEVA
JNJ
PFE
BMY
LLY
VRTX
AMGN
ABBV
GILD
BIIB
CSL
Urinary Tract Infection Treatment Market Competitor Analysis Report 2025: Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, Key Persons and Revenue
globenewswire.com
GSK
PFE
MRK